Real-time enrollment status for this pids linked to pi3k clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:09 PM UTC
| NCT Number | NCT06990529 |
| Recruiting Status | Recruiting |
| Condition | PIDs Linked to PI3K |
| Phase | Clinical Trial |
| Target Enrollment | 12 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Pharming Technologies B.V. |
| Last Updated on CT.gov | February 13, 2026 (Feb 13, 2026) |
As of July 13, 2026: Clinical trial NCT06990529 is currently recruiting participants. This clinical trial study for pids linked to pi3k is actively seeking new participants at 3 locations across the United States. The study is sponsored by Pharming Technologies B.V.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06990529 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06990529 was last updated Feb 13, 2026 (February 13, 2026). HelloStudys verifies this status automatically.